Annual EBIT
-$176.91 M
-$154.56 M-691.65%
December 31, 2023
Summary
- As of February 26, 2025, NAMS annual earnings before interest & taxes is -$176.91 million, with the most recent change of -$154.56 million (-691.65%) on December 31, 2023.
- During the last 3 years, NAMS annual EBIT has fallen by -$170.26 million (-2561.14%).
- NAMS annual EBIT is now -2561.14% below its all-time high of -$6.65 million, reached on December 1, 2020.
Performance
NAMS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$23.87 M
+$27.53 M+53.56%
September 30, 2024
Summary
- As of February 26, 2025, NAMS quarterly earnings before interest & taxes is -$23.87 million, with the most recent change of +$27.53 million (+53.56%) on September 30, 2024.
- Over the past year, NAMS quarterly EBIT has stayed the same.
- NAMS quarterly EBIT is now at all-time high.
Performance
NAMS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$180.85 M
+$24.41 M+11.89%
September 30, 2024
Summary
- As of February 26, 2025, NAMS TTM earnings before interest & taxes is -$180.85 million, with the most recent change of +$24.41 million (+11.89%) on September 30, 2024.
- Over the past year, NAMS TTM EBIT has stayed the same.
- NAMS TTM EBIT is now -368.20% below its all-time high of -$38.63 million, reached on March 31, 2023.
Performance
NAMS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NAMS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -691.6% | 0.0% | 0.0% |
| 3 y3 years | -2561.1% | - | - |
| 5 y5 years | -2561.1% | - | - |
NAMS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -691.6% | at low | at high | +56.3% | -368.2% | +11.9% |
| 5 y | 5-year | -2561.1% | at low | at high | +56.3% | -368.2% | +11.9% |
| alltime | all time | -2561.1% | at low | at high | +56.3% | -368.2% | +11.9% |
NewAmsterdam Pharma Company NV EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$23.87 M(-53.6%) | -$180.85 M(-11.9%) |
| Jun 2024 | - | -$51.40 M(-5.8%) | -$205.27 M(+6.4%) |
| Mar 2024 | - | -$54.59 M(+7.0%) | -$192.87 M(+9.0%) |
| Dec 2023 | -$176.91 M | -$51.00 M(+5.6%) | -$176.91 M(+40.5%) |
| Sep 2023 | - | -$48.28 M(+23.8%) | -$125.91 M(+62.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$39.00 M(+1.0%) | -$77.63 M(+101.0%) |
| Mar 2023 | - | -$38.63 M | -$38.63 M |
| Dec 2022 | -$22.35 M(-46.0%) | - | - |
| Dec 2021 | -$41.37 M(+522.4%) | - | - |
| Dec 2020 | -$6.65 M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual EBIT year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly EBIT year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM EBIT year-on-year change?
What is NewAmsterdam Pharma Company NV annual earnings before interest & taxes?
The current annual EBIT of NAMS is -$176.91 M
What is the all time high annual EBIT for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual earnings before interest & taxes is -$6.65 M
What is NewAmsterdam Pharma Company NV annual EBIT year-on-year change?
Over the past year, NAMS annual earnings before interest & taxes has changed by -$154.56 M (-691.65%)
What is NewAmsterdam Pharma Company NV quarterly earnings before interest & taxes?
The current quarterly EBIT of NAMS is -$23.87 M
What is the all time high quarterly EBIT for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly earnings before interest & taxes is -$23.87 M
What is NewAmsterdam Pharma Company NV quarterly EBIT year-on-year change?
Over the past year, NAMS quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is NewAmsterdam Pharma Company NV TTM earnings before interest & taxes?
The current TTM EBIT of NAMS is -$180.85 M
What is the all time high TTM EBIT for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM earnings before interest & taxes is -$38.63 M
What is NewAmsterdam Pharma Company NV TTM EBIT year-on-year change?
Over the past year, NAMS TTM earnings before interest & taxes has changed by $0.00 (0.00%)